Photo of Bexis

Here’s my thesis: Bexis keeps winning all these cases just so Herrmann is saddled with the responsibility of writing ’em up on the blog. The SOB is a malingerer, pure and simple.

Today’s news is Sinclair v. Merck & Co, No. A-117-06, slip op. (N.J. June 4, 2008). We linked to it moments ago. And

Photo of Bexis

We’ve just received word that the NJ Supreme Court has ruled in the Sinclair Vioxx appeal:

“HELD: The Products Liability Act, which is the sole source of remedy for plaintiffs’ defective product claim, does not include the remedy of medical monitoring when no manifest injury is alleged.”

Until Herrmann gets a chance to read the

Photo of Bexis

As readers of this blog know, Bexis’ firm is involved in the Vioxx litigation. This post, like all of the others about the Vioxx litigation, represents Herrmann’s work alone:

Many folks interpreted the Vioxx settlement agreement to require participating plaintiffs’ counsel to (1) recommend to all of their clients that they participate in the settlement,

Photo of Bexis

The American Enterprise Institute hosted a panel discussion on Monday about the Vioxx settlement.
C-SPAN (and C-SPAN 2) broadcast the event yesterday, but without much advance notice.

Photo of Bexis

At noon on this Monday, January 7, 2008, one of your humble scribes — Herrmann — will participate in a panel at the American Enterprise Institute in Washington, D.C., to discuss the Vioxx settlement.
With one small exception, the AEI has lined up an all-star cast. In the words of the program description:
“Speakers include